HomeNewsBusinessMC Exclusive: Go First looking at three fleet-size options to restart operations

MC Exclusive: Go First looking at three fleet-size options to restart operations

The airline’s plans hinge on whether aircraft lessors will be allowed to take back their planes.

May 19, 2023 / 19:44 IST
Story continues below Advertisement
Go First
Go First

Go First will seek approval early next week to resume flights with three fleet-size options, depending on how many aircraft lessors are allowed to take back.

The airline will approach the civil aviation ministry and the Directorate General of Civil Aviation (DGCA) with its plans to restart operations, people aware of the development said.

Story continues below Advertisement

“Three sets of plans have been prepared by Go First, which involves restarting operations with a fleet of seven planes, 15 planes, and 20 planes,” one person said. The plans will be submitted once the airline gets clarity on how many planes it can operate, the person added.

Go First's plans

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show